Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which su...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3737217?pdf=render |
id |
doaj-9887dfa4c3d447f9a1ad00c856c851ba |
---|---|
record_format |
Article |
spelling |
doaj-9887dfa4c3d447f9a1ad00c856c851ba2020-11-25T01:32:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e6900110.1371/journal.pone.0069001Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.Chun-Fang WangGuo ZhangLi-Jun ZhaoWen-Juan QiXiao-Ping LiJian-Liu WangLi-Hui WeiEpidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which suggests that IR-A-mediated signaling pathways may have important implications for cancer pathogenesis. We measured the expression of insulin receptor isoforms (IR-A and IR-B in the normal endometrium tissues, the endometrial carcinoma tissues and the endometrial carcinoma cell lines. We found that the total insulin receptor (IR) and IR-A expression mRNA levels and the ratio of IR-A to total IR in endometrial carcinoma specimens were significantly higher than them in control endometrial tissue specimens(P<0.05). Further analysis indicated that the tendency was more prominently in patients with T2DM. IR-A mRNA was differentially expressed in four endometrial carcinoma cell lines (Ishikawa, KLE, RL95-2 and HEC-1-A. RL95-2 cells have a low endogenous IR-A expression, and these were used to construct a stable cell line overexpressing IR-A. We found that IR-A overexpression significantly increased cell proliferation, the proportion of cells in S phase, activation of the Akt pathway and tumorigenicity of xenografts in nude mice. In contrast, there was no significant difference in the the percentage of apoptotic cells between cells overexpressing IR-A and control cells. Moreover, levels of phosphorylated ERK1/2 protein were significantly decreased in cells overexpressing IR-A relative to controls. These findings reveal the pivotal role of IR-A in endometrial cancer carcinogenesis, and suggest that the association of elevated IR-A levels with cell proliferation and tumorigenicity may be causally linked to its effect on the proportion of cells in S phase and the activation of the Akt pathway.http://europepmc.org/articles/PMC3737217?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chun-Fang Wang Guo Zhang Li-Jun Zhao Wen-Juan Qi Xiao-Ping Li Jian-Liu Wang Li-Hui Wei |
spellingShingle |
Chun-Fang Wang Guo Zhang Li-Jun Zhao Wen-Juan Qi Xiao-Ping Li Jian-Liu Wang Li-Hui Wei Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. PLoS ONE |
author_facet |
Chun-Fang Wang Guo Zhang Li-Jun Zhao Wen-Juan Qi Xiao-Ping Li Jian-Liu Wang Li-Hui Wei |
author_sort |
Chun-Fang Wang |
title |
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. |
title_short |
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. |
title_full |
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. |
title_fullStr |
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. |
title_full_unstemmed |
Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. |
title_sort |
overexpression of the insulin receptor isoform a promotes endometrial carcinoma cell growth. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which suggests that IR-A-mediated signaling pathways may have important implications for cancer pathogenesis. We measured the expression of insulin receptor isoforms (IR-A and IR-B in the normal endometrium tissues, the endometrial carcinoma tissues and the endometrial carcinoma cell lines. We found that the total insulin receptor (IR) and IR-A expression mRNA levels and the ratio of IR-A to total IR in endometrial carcinoma specimens were significantly higher than them in control endometrial tissue specimens(P<0.05). Further analysis indicated that the tendency was more prominently in patients with T2DM. IR-A mRNA was differentially expressed in four endometrial carcinoma cell lines (Ishikawa, KLE, RL95-2 and HEC-1-A. RL95-2 cells have a low endogenous IR-A expression, and these were used to construct a stable cell line overexpressing IR-A. We found that IR-A overexpression significantly increased cell proliferation, the proportion of cells in S phase, activation of the Akt pathway and tumorigenicity of xenografts in nude mice. In contrast, there was no significant difference in the the percentage of apoptotic cells between cells overexpressing IR-A and control cells. Moreover, levels of phosphorylated ERK1/2 protein were significantly decreased in cells overexpressing IR-A relative to controls. These findings reveal the pivotal role of IR-A in endometrial cancer carcinogenesis, and suggest that the association of elevated IR-A levels with cell proliferation and tumorigenicity may be causally linked to its effect on the proportion of cells in S phase and the activation of the Akt pathway. |
url |
http://europepmc.org/articles/PMC3737217?pdf=render |
work_keys_str_mv |
AT chunfangwang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT guozhang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT lijunzhao overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT wenjuanqi overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT xiaopingli overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT jianliuwang overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth AT lihuiwei overexpressionoftheinsulinreceptorisoformapromotesendometrialcarcinomacellgrowth |
_version_ |
1725083122206244864 |